SG11202105169WA - Transmembrane domain derived from human lrrc24 protein - Google Patents
Transmembrane domain derived from human lrrc24 proteinInfo
- Publication number
- SG11202105169WA SG11202105169WA SG11202105169WA SG11202105169WA SG11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA SG 11202105169W A SG11202105169W A SG 11202105169WA
- Authority
- SG
- Singapore
- Prior art keywords
- protein
- transmembrane domain
- domain derived
- lrrc24
- human
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180165438 | 2018-12-19 | ||
| KR1020190144779A KR102351041B1 (en) | 2018-12-19 | 2019-11-13 | Cell penetrating Domain derived from human LRRC24 protein |
| PCT/KR2019/017829 WO2020130547A1 (en) | 2018-12-19 | 2019-12-16 | Transmembrane domain derived from human lrrc24 protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105169WA true SG11202105169WA (en) | 2021-06-29 |
Family
ID=71401249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105169WA SG11202105169WA (en) | 2018-12-19 | 2019-12-16 | Transmembrane domain derived from human lrrc24 protein |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220306718A1 (en) |
| EP (1) | EP3875113A4 (en) |
| JP (1) | JP7193633B2 (en) |
| KR (1) | KR102351041B1 (en) |
| CN (1) | CN113166216A (en) |
| AU (1) | AU2019403533A1 (en) |
| BR (1) | BR112021012019A2 (en) |
| CA (1) | CA3122428A1 (en) |
| PH (1) | PH12021551150A1 (en) |
| SG (1) | SG11202105169WA (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102484312B1 (en) * | 2020-05-14 | 2023-01-02 | 한국화학연구원 | High potency severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) antigen and vaccine composition comprising the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004020595A2 (en) * | 2002-08-29 | 2004-03-11 | Five Prime Therapeutics, Inc. | Novel human polypeptides encoded by polynucleotides |
| US20110033389A1 (en) * | 2009-04-29 | 2011-02-10 | Zhifeng Chen | Modified antibodies for passive immunotherapy |
| US10723806B2 (en) * | 2012-02-27 | 2020-07-28 | Riken | Method of introducing nucleic acid into plant cells |
| US10967000B2 (en) * | 2012-07-11 | 2021-04-06 | Gemvax & Kael Co., Ltd. | Cell-penetrating peptide, conjugate comprising same and composition comprising same |
| KR102166542B1 (en) * | 2012-09-28 | 2020-10-16 | 주식회사 젬백스앤카엘 | Conjugate of telomerase derived peptide and contrast substances for detecting stem cell and Contrast composition comprising the same |
| ES2722924T3 (en) * | 2012-12-05 | 2019-08-20 | Univ Heidelberg Ruprecht Karls | Conjugates of multivalent cell penetration proteins and peptides and their uses |
| US20150329640A1 (en) * | 2012-12-20 | 2015-11-19 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| US20180133327A1 (en) * | 2015-03-16 | 2018-05-17 | Amal Therapeutics Sa | Cell Penetrating Peptides and Complexes Comprising the Same |
| CN107636017B (en) * | 2015-04-10 | 2022-05-31 | 费尔丹生物公司 | Polypeptide-based shuttle agents for improving the efficiency of transduction of a polypeptide cargo into the cytoplasm of a target eukaryotic cell, uses thereof, and methods and kits related thereto |
| CN105112383B (en) * | 2015-08-25 | 2018-12-14 | 三峡大学 | Penetratin hPP5 and application thereof |
| CN105175526B (en) * | 2015-08-25 | 2018-08-14 | 三峡大学 | Penetratin hPP8 and application thereof |
| JP7250519B2 (en) * | 2016-03-23 | 2023-04-03 | ヘルムホルツ ツェントゥルム ミュンヘン ドイチェス フォルシュングスツェントゥルム フューア ゲズントハイト ウント ウムヴェルト （ゲーエムベーハー） | Fusion protein of PD-1 and 4-1BB |
| KR101848147B1 (en) * | 2016-07-14 | 2018-04-11 | 건양대학교산학협력단 | HOXA9 cell-permeable fusion protein and composition comprising the same for preventing or treating of lung cancer |
| IL249610A (en) * | 2016-12-15 | 2017-12-31 | Nat Inst Biotechnology Negev Ltd | Fusion proteins for treatment of cancer |
-
2019
- 2019-11-13 KR KR1020190144779A patent/KR102351041B1/en active IP Right Grant
- 2019-12-16 EP EP19898351.2A patent/EP3875113A4/en active Pending
- 2019-12-16 CN CN201980079173.8A patent/CN113166216A/en active Pending
- 2019-12-16 JP JP2021531077A patent/JP7193633B2/en active Active
- 2019-12-16 AU AU2019403533A patent/AU2019403533A1/en active Pending
- 2019-12-16 SG SG11202105169WA patent/SG11202105169WA/en unknown
- 2019-12-16 US US17/296,622 patent/US20220306718A1/en active Pending
- 2019-12-16 CA CA3122428A patent/CA3122428A1/en active Pending
- 2019-12-16 BR BR112021012019A patent/BR112021012019A2/en not_active IP Right Cessation
-
2021
- 2021-05-20 PH PH12021551150A patent/PH12021551150A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113166216A (en) | 2021-07-23 |
| EP3875113A4 (en) | 2022-08-31 |
| JP2022510309A (en) | 2022-01-26 |
| KR20200076582A (en) | 2020-06-29 |
| AU2019403533A1 (en) | 2021-06-24 |
| JP7193633B2 (en) | 2022-12-20 |
| CA3122428A1 (en) | 2020-06-25 |
| KR102351041B1 (en) | 2022-01-13 |
| EP3875113A1 (en) | 2021-09-08 |
| US20220306718A1 (en) | 2022-09-29 |
| PH12021551150A1 (en) | 2021-11-03 |
| BR112021012019A2 (en) | 2021-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279505A (en) | Chimeric transmembrane proteins and uses thereof | |
| IL274842A (en) | Cream substitute comprising pulse protein | |
| IL281804A (en) | Protein purification methods | |
| AU201815210S (en) | Chair | |
| DK3737402T3 (en) | Modificeret protein | |
| GB201711481D0 (en) | Protein purification | |
| AU201815213S (en) | Chair | |
| AU201813716S (en) | Chair | |
| PL3898217T3 (en) | Tissue product | |
| IL279355A (en) | Anti-steap1 antigen-binding protein | |
| GB201819434D0 (en) | Domain adaptation | |
| IL273898A (en) | Vesicle incorporating transmembrane protein | |
| ZA201906029B (en) | Novel insect inhibitory proteins | |
| IL278839A (en) | Suture system | |
| GB201701438D0 (en) | Skine tissue | |
| SG11202105169WA (en) | Transmembrane domain derived from human lrrc24 protein | |
| EP3401324A4 (en) | Novel protein transduction domain and use thereof | |
| IL283212A (en) | Anti-waste sanitary system | |
| IL277747B (en) | Suturing system | |
| GB2612914B (en) | Tissue analysis | |
| GB2592507B (en) | Forceps | |
| GB201819164D0 (en) | Artificial-intelligence-assisted surgery | |
| EP3615561C0 (en) | Variants of human bmp7 protein | |
| IL290368A (en) | Modified human variable domains | |
| AU2018902889A0 (en) | Methods of inhibiting transmembrane proteins |